Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: Am J Cardiol. 2014 Mar 1;113(10):1599–1605. doi: 10.1016/j.amjcard.2014.02.010

Table 4.

IMMEDIATE TRIAL INCIDENCE OF IN-HOSPITAL CARDIAC ARREST/1-YEAR MORTALITY OVERALL AMONG PATIENTS PRESENTING WITH ECG ST ELEVATION

Outcome Treatment Unadjusted
Rates
Unadjusted
Kaplan-
Meier Rate
Unadjusted
Hazard
Ratio (GIK
vs.
Placebo)
95%
Confidence
Interval of
95%
Unadjusted
Hazard
Ratio
Unadjusted
Cox
Regression
P-Value
1-Year Mortality GIK 13/163 (8.0%) 8.3% 0.65 0.33, 1.27 0.208
Placebo 24/194 (12.4%) 12.6%
Cardiac Arrest or Mortality GIK 17/163 (10.4%) 10.8% 0.52 0.30, 0.92 0.025
Placebo 37/194 (19.1%) 19.3%
In-hospital Cardiac Arrest GIK 9/163 (5.5%) 0.49 0.23, 1.03 0.061
Placebo 21/194 (10.8%)
1-Year HF or Mortality GIK 16/163 (9.8%) 10.2% 0.63 0.35, 1.16 0.139
Placebo 30/194 (15.5%) 15.7%
1-Year HF GIK 6/163 (3.7%) 4.2% 0.65 0.24, 1.74 0.389
Placebo 11/194 (5.7%) 6.1%
Cardiac arrest, HF, or Mortality GIK 19/163 (11.7%) 12.0% 0.51 0.30, 0.87 0.014
Placebo 42/194 (21.6%) 21.9%